Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
From Benzinga
 
   EMA's Risk Assessment Committee Finds Link Of Rare Cases Between JNJ COVID-19 Shot, Blood Clots
   
  
  
  October 01, 2021
  From Benzinga
 
   Qiagen Secures DoD Contract To Boost Production Capacity For NeuMoDx
   
  October 01, 2021
  Tickers 
   QGEN
  
  
  From Benzinga
 
   AstraZeneca COVID-19 Jab Shows 74% Efficacy In US Trial
   
  
  
  September 30, 2021
  From Benzinga
 
   Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
   
  
  
  September 30, 2021
  From Benzinga
 
   Merck's COVID-19 Antiviral Pill Effective Against Variants, Lab Studies Show
   
  
  
  September 29, 2021
  From Benzinga
 
   NIH-Backed US Study Of Mixed COVID-19 Vaccines Regime To Conclude Soon: CNBC
   
  
  
  September 29, 2021
  From Benzinga
 
   Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
   
  
  
  September 29, 2021
  From Benzinga
 
   Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know
   
  
  
  September 28, 2021
  From Benzinga
 
   AstraZeneca, Sputnik Light COVID-19 Vaccine Mix Shows Strong Antibody Growth: Reuters
   
  
  
  September 27, 2021
  From Benzinga
 
   Glaxo - Vir Biotech's COVID Treatment Approved In Japan
   
  
  
  September 27, 2021
  From Benzinga
 
   Pfizer Kick Starts Late-Stage Study For COVID-19 Oral Antiviral For Post-Exposure Prophylaxis
   
  September 27, 2021
  Tickers 
   PFE
  
  
  From Benzinga
 
   NRx Pharma's COVID-19 Candidate Shows Improved Survival At One Year
   
  September 27, 2021
  Tickers 
   NRXP
  
  
  From Benzinga
 
   FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
   
  
  
  September 24, 2021
  From Benzinga
 
   WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access
   
  
  
  September 24, 2021
  From Benzinga
 
   Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters
   
  
  
  September 24, 2021
  From Benzinga
 
   Pfizer/BioNTech COVID-19 Boosters For Seniors, Certain Vulnerable Adults Coming Soon - CDC Panel Recommends
   
  
  
  September 24, 2021
  From Benzinga
 
   Novavax Shares Gain After Filing With Serum Institute For WHO Emergency Use Listing For COVID-19 Vaccine
   
  September 23, 2021
  Tickers 
   NVAX
  
  
  From Benzinga
 
   EMA To Decide On Pfizer/BioNTech COVID-19 Booster Next Month: Reuters
   
  
  
  September 23, 2021
  From Benzinga
 
   OraSure Secures $13.6M BARDA Funding For InteliSwab COVID-19 Test 510(k) Clearance and CLIA Waiver
   
  September 23, 2021
  Tickers 
   OSUR
  
  
  From Benzinga
 
   Valneva Continues To Expand COVID-19 Vaccine Candidate Trials
   
  September 23, 2021
  Tickers 
   VALN
  
  
  From Benzinga
 
   Vietnam's Health Ministry Approves Phase 2, Phase 3 Cohorts Of Arcturus' COVID-19 Vaccine Trial
   
  September 22, 2021
  Tickers 
   ARCT
  
  
  From Benzinga
 
   Why Are Dynavax Technologies Shares Skyrocketing Today?
   
  September 22, 2021
  Tickers 
   DVAX
  
  
  From Benzinga
 
   Immunic, University Medical Center Goettingen Ink Licensing Pact For Combination Viral Infection Treatments
   
  September 22, 2021
  Tickers 
   IMUX
  
  
  From Benzinga
 
   Corvus Posts Data From Discontinued Mupadolimab COVID-19 Program
   
  September 22, 2021
  Tickers 
   CRVS
  
  
  From Benzinga
 
   US To Donate Additional 500M Pfizer-BioNTech COVID-19 Vaccine Doses To Lower Income Nations
   
  
  
  September 22, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.